Pharmaceutical Research and Manufacturers of America v. Walsh

Summary

The Supreme Court affirmed the First Circuit's judgment vacating the preliminary injunction against Maine's Rx Program. The Court held that petitioner failed to show a probability of success on pre-emption or Commerce Clause claims at this stage. The Medicaid Act permits prior authorization and grants states discretion, and the program does not regulate out-of-state prices or discriminate against interstate commerce.